Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Pipeline Watch: Phase II/III Start With Nipocalimab, Phase III With Verdiperstat

Mon, 08/05/2019 - 5:33am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Multiple Firsts As Pexidartinib Approved In US - With Warning

Sun, 08/04/2019 - 8:50pm

Further progress for Daiichi Sankyo's strategic push into oncology as US issues first approval globally for first-in-class rare disease drug...

      Related Stories 

Almirall’s Dermatology Pitch Takes Shape

Sun, 08/04/2019 - 3:39pm

CEO Peter Guenter’s focus on first- and best-in-class looks like the right strategy as Spanish pharma builds critical mass in...

      Related Stories 

Timeline: Almirall's Pivot To Dermatology

Sun, 08/04/2019 - 3:34pm

As Almirall's dermatology strategy bears commercial fruits, Scrip examines the key steps in its transformation, its recent financial performance, and...

      Related Stories 

Finance Watch: Cell And Gene Therapy Fundraising Down Overall In Q2, But VC Deals Still Soared

Fri, 08/02/2019 - 1:20pm

Private Company Edition: ARM's Q2 report shows a 38% decline in financings, but venture capital and upfront fees from deals...

      Related Stories 

Indivior Submits Products For Approval Outside The US, Where Pressures Mount

Fri, 08/02/2019 - 8:05am

Indivior is working on receiving ex-US approvals for its opioid abuse treatment products and building its cash reserves but faces...

      Related Stories 

Lachman CEO On Compliance And Living The Code Of Conduct

Fri, 08/02/2019 - 7:38am

Frances Zipp, president and CEO of Lachman Consultant Services, Inc, in an interview with Scrip, emphasizes the importance of the...

      Related Stories 

Want To Fly In China‘s New Normal? Learn From Merck

Fri, 08/02/2019 - 12:54am

Many multinationals are banking on novel drug products to capture China’s new growth spurt as it transforms to care centered...

      Related Stories 

Tivozanib Non-Oncology Buy-Back Gives Quick Cash To AVEO

Thu, 08/01/2019 - 10:03pm

In a move that will generate further useful cash for AVEO, Kyowa Kirin has reacquired global rights to non-oncology uses...

      Related Stories 

Ready To Make Bigger Biotech Investments, Vida Raises $600m For Second Fund

Thu, 08/01/2019 - 2:25pm

Scrip spoke with Fred Cohen, who co-founded Vida Ventures with former Kite Pharma CEO Arie Belldegrun, about the venture capital...

      Related Stories 

Roche’s Pipeline Prospects Promise Steady Sailing To More Growth

Thu, 08/01/2019 - 8:36am

Analysts increasingly see Roche’s pipeline and newly launched drugs winning over investors and neutralizing worries over biosimilars and potential US...

      Related Stories 

Italfarmaco Options Inhaled Teicoplanin For MRSA Lung Infections

Thu, 08/01/2019 - 8:10am

Italfarmaco and Neupharma plan to collaborate on the development of a new inhaled formulation of a Gram-positive targeted antibiotic for...

      Related Stories 

J&J Drops Alligator’s MAb ADC-1013 After Reviewing Combination Data

Thu, 08/01/2019 - 5:23am

The anti-CD40 antibody underperformed in some preclinical cancer combination studies, leading J&J to prioritize other assets. Alligator Bioscience will now...

      Related Stories 

Takeda Keen To Show Shire Integration On Track

Wed, 07/31/2019 - 9:16pm

Takeda was keen to highlight at its first-quarter briefing the progress towards what it sees as the smooth global integration...

      Related Stories 

Pages